Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar

INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in M...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez, Lara K, Chaillon, Antoine, Soe, Kyi Pyar, Johnson, Derek C, Zosso, Jean-Marc, Incerti, Andrea, Loarec, Anne, Nguyen, Aude, Walker, Josephine G, Mafirakureva, Nyashadzaishe, Lo Re III, Vincent, Wynn, Adriane, McIntosh, Craig, Kiene, Susan M, Brodine, Stephanie, Garfein, Richard S, Vickerman, Peter, Martin, Natasha K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908309/
https://www.ncbi.nlm.nih.gov/pubmed/33627360
http://dx.doi.org/10.1136/bmjgh-2020-004181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908309/
https://www.ncbi.nlm.nih.gov/pubmed/33627360
http://dx.doi.org/10.1136/bmjgh-2020-004181

Ejemplares similares